Mupirocin and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Mupirocin (mupirocin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Mupirocin. It is created by eHealthMe based on reports of 5,867 people who have side effects when taking Mupirocin from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,750 drugs and 2,915 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,867 people reported to have side effects when taking Mupirocin.
Among them, 51 people (0.87%) have Hypersensitivity.

Among these 51 people:

How long have people been on Mupirocin when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Mupirocin? *

female: 73.91 %
male: 26.09 %

What is the age of people who have Hypersensitivity when taking Mupirocin? *

What are other drugs people take besides Mupirocin? *

What are other side effects people have besides Hypersensitivity? *

Rashes (redness): 12 people, 23.53%
Chest Pain: 10 people, 19.61%
Dyspnea (difficult or laboured breathing): 9 people, 17.65%
Nausea (feeling of having an urge to vomit): 8 people, 15.69%
Sinusitis (inflammation of sinus): 7 people, 13.73%
Infusion Related Reaction: 7 people, 13.73%
Neck Pain: 7 people, 13.73%
Hypotension (abnormally low blood pressure): 6 people, 11.76%
Cardiac Arrest: 6 people, 11.76%
Heparin-Induced Thrombocytopenia: 6 people, 11.76%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 15.69%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 7.84%
Sinusitis (inflammation of sinus): 3 people, 5.88%
Pain: 3 people, 5.88%
Asthma: 3 people, 5.88%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 3.92%
Drowsiness: 2 people, 3.92%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 3.92%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 3.92%
Fever: 2 people, 3.92%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mupirocin:

Mupirocin (5,940 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,750 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,915 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Mupirocin) and Mupirocin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.